Extracellular signal-regulated kinase 8-mediated c-Jun phosphorylation increases tumorigenesis of human colon cancer

Cancer Research

Volumn 70, Issue 8, 2010, Pages 3218-3227

  Xu, Yan Ming ^a   Zhu, Feng ^a   Cho, Yong Yeon ^a   Carper, Andria ^a   Peng, Cong ^a   Zheng, Duo ^a   Yao, Ke ^a   Lau, Andy T Y ^a   Zykova, Tatyana A ^a   Kim, Hong Gyum ^a   Bode, Ann M ^a   Dong, Zigang ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EXTRACELLULAR SIGNAL REGULATED KINASE 8; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN C JUN; SERINE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSIENT TRANSFECTION;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; DISEASE PROGRESSION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENES, REPORTER; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MICE, NUDE; PHOSPHORYLATION; RNA, SMALL INTERFERING; SERINE;

EID: 77951087217     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-4306     Document Type: Article

References (43)

1. Lewis TS, Shapiro PS, Ahn NG. Signal transduction through MAP kinase cascades. Adv Cancer Res 1998;74:49-139. (Pubitemid 28193546)
2. Pearson G, Robinson F, Beers Gibson T, et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 2001;222:153-183 (Pubitemid 32458157)
3. Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 1997;92:180-186
4. Waskiewicz AJ, Cooper JA. Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast. Curr Opin Cell Biol 1995;76:798-805.
5. Sugden PH, Clerk A. Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors. Cell Signal 1997;95:337-351 (Pubitemid 27367575)
6. Kamakura S, Moriguchi T, Nishida E. Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus. J Biol Chem 1999;27437:26563-26571 (Pubitemid 129520095)
7. Abe MK, Saelzler MP, Espinosa R III, et al. ERK8, a new member of the mitogen-activated protein kinase family. J Biol Chem 2002;27719:16733-16743 (Pubitemid 34967694)
8. Abe MK, Kahle KT, Saelzler MP, Orth K, Dixon JE, Rosner MR. ERK7 is an autoactivated member of the MAPK family. J Biol Chem 2001;27624:21272-21279 (Pubitemid 37413117)
9. Iavarone C, Acunzo M, Carlomagno F, et al. Activation of the Erk8 mitogen-activated protein (MAP) kinase by RET/PTC3, a constitutively active form of the RET proto-oncogene. J Biol Chem 2006;28115:10567-10576 (Pubitemid 43864598)
10. Saelzler MP, Spackman CC, Liu Y, Martinez LC, Harris JP, Abe MK. ERK8 down-regulates transactivation of the glucocorticoid receptor through Hic-5. J Biol Chem 2006;28124:16821-16832 (Pubitemid 43909638)
11. Maki Y, Bos TJ, Davis C, Starbuck M, Vogt PK. Avian sarcoma virus 17 carries the jun oncogene. Proc Natl Acad Sci U S A 1987;849:2848-2852
12. Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol 2002;45:E131-6. (Pubitemid 34521026)
13. Binetruy B, Smeal T, Karin M. Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain. Nature 1991;3516322:122-127 (Pubitemid 21896543)
14. Hibi M, Lin A, Smeal T, Minden A, Karin M. Identification of an oncoprotein-and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 1993;711:2135-2148 (Pubitemid 23336140)
15. Pulverer BJ, Kyriakis JM, Avruch J, Nikolakaki E, Woodgett JR. Phosphorylation of c-jun mediated by MAP kinases. Nature 1991;3536345:670-674 (Pubitemid 21912588)
16. Smeal T, Binetruy B, Mercola D, et al. Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73. Mol Cell Biol 1992;128:3507-3513
17. Huang C, Ma WY, Young MR, Colburn N, Dong Z. Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells. Proc Natl Acad Sci U S A 1998;951:156-161 (Pubitemid 28103923)
18. Derijard B, Hibi M, Wu IH, et al. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994;766:1025-1037 (Pubitemid 24106383)
19. Kyriakis JM, Banerjee P, Nikolakaki E, et al. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 1994;3696476:156-160 (Pubitemid 24153440)
20. Dong Z, Lavrovsky V, Colburn NH. Transformation reversion induced in JB6 RT101 cells by AP-1 inhibitors. Carcinogenesis 1995;164:749-756
21. Morton S, Davis RJ, McLaren A, Cohen P. A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO J 2003;2215:3876-3886 (Pubitemid 36975714)
22. 73 enhances cell transformation. Cancer Res 2009;691:272-281
23. Zhu F, Choi BY, Ma WY, et al. COOH-terminal Src kinase-mediated c-Jun phosphorylation promotes c-Jun degradation and inhibits cell transformation. Cancer Res 2006;6611:5729-5736 (Pubitemid 43927126)
24. Tomayko MM, Reynolds CP. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 1989;243:148-154
25. Klevernic IV, Stafford MJ, Morrice N, Peggie M, Morton S, Cohen P. Characterization of the reversible phosphorylation and activation of ERK8. Biochem J 2006;394Pt 1:365-373 (Pubitemid 43259686)
26. Bogoyevitch MA, Court NW. Counting on mitogen-activated protein kinases - ERKs 3, 4, 5, 6, 7 and 8. Cell Signal 2004;1612:1345-1354
27. Bernstein LR, Colburn NH. AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells. Science 1989;2444904:566-569
28. Musti AM, Treier M, Bohmann D. Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases. Science 1997;2755298:400-402 (Pubitemid 27051620)
29. Crews CM, Alessandrini A, Erikson RL. The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. Science 1992;2585081:478-480
30. Kolch W. Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat Rev Mol Cell Biol 2005;611:827-837 (Pubitemid 41568732)
31. Viala E, Pouyssegur J. Regulation of tumor cell motility by ERK mitogen-activated protein kinases. Ann N Y Acad Sci 2004;1030:208-218 (Pubitemid 40378916)
32. Henrich LM, Smith JA, Kitt D, et al. Extracellular signal-regulated kinase 7, a regulator of hormone-dependent estrogen receptor destruction. Mol Cell Biol 2003;2317:5979-5988 (Pubitemid 37013079)
33. Chapman S, Asthagiri AR. Resistance to signal activation governs design features of the MAP kinase signaling module. Biotechnol Bioeng 2004;853:311-322 (Pubitemid 38182224)
34. Fang JY, Richardson BC. The MAPK signalling pathways and colorectal cancer. Lancet Oncol 2005;65:322-327
35. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 1995;27028:16483-16486
36. Hill CS, Wynne J, Treisman R. Serum-regulated transcription by serum response factor (SRF): a novel role for the DNA binding domain. EMBO J 1994;1322:5421-5432 (Pubitemid 2155679)
37. Angel P, Imagawa M, Chiu R, et al. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 1987;496:729-739 (Pubitemid 18094763)
38. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991;1072:129-157
39. Vogt PK. Jun, the oncoprotein. Oncogene 2001;2019:2365-2377
40. Maeda S, Karin M. Oncogene at last - c-Jun promotes liver cancer in mice. Cancer Cell 2003;32:102-104 (Pubitemid 37443382)
41. Arias J, Alberts AS, Brindle P, et al. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 1994;3706486:226-229 (Pubitemid 24236780)
42. 63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro. Oncogene 1995;1112:2509-2514
43. Bost F, Caron L, Vial E, et al. The defective transforming phenotype of c-Jun Ala(63/73) is rescued by mutation of the C-terminal phosphorylation site. Oncogene 2001;2050:7425-7429 (Pubitemid 33078214)